...offers that are significantly higher than those it has already received. This year, Synergy granted Shandong Luoxin Pharmaceutical Group Stock Co. Ltd....
...Business: Gastrointestinal Jaime De Leon Trulance (Brand), SP-304 (Former compound #), guanilib (Former generic), plecanatide (Generic), Trulance (Other) Shandong Luoxin Pharmaceutical Group Stock Co. Ltd. Synergy...

...about $605 million. That same year, GL Capital, Ally Bridge and Giant Star Global took Shandong Luoxin Pharmaceutical Group Stock Co. Ltd....

...about $605 million. That same year, GL Capital, Ally Bridge and Giant Star Global took Shandong Luoxin Pharmaceutical Group Stock Co. Ltd....
...HK$17 per share, or about HK$2.3 billion ($293 million). Elizabeth S. Eaton China Biologic Products Holdings Inc. GL Capital Luoxin Pharmaceutical Oxford...

...Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) granted Shandong Luoxin Pharmaceutical Group Stock Co. Ltd. (Linyi, China) exclusive rights to develop and commercialize gastrointestinal drug...
...Synergy added $0.03 to $1.63 on Aug. 7. Synergy Pharmaceuticals Inc. (NASDAQ:SGYP), New York, N.Y. Shandong Luoxin Pharmaceutical Group Stock Co. Ltd....
...China Business: Gastrointestinal Sandi Wong Trulance (Brand), SP-304 (Former compound #), guanilib (Former generic), plecanatide (Generic), Trulance (Other) Shandong Luoxin Pharmaceutical Group Stock Co. Ltd. Synergy...

...Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) granted Shandong Luoxin Pharmaceutical Group Stock Co. Ltd. (Linyi, China) exclusive rights to develop and commercialize gastrointestinal drug...
...$1.63 on Tuesday. Sandi Wong Trulance (Brand), SP-304 (Former compound #), guanilib (Former generic), plecanatide (Generic), Trulance (Other) Shandong Luoxin Pharmaceutical Group Stock Co. Ltd. Synergy...

...territory. In March, GL Capital, Ally Bridge and Giant Star Global proposed to take private Shandong Luoxin Pharmaceutical Group Stock Co. Ltd....

...territory. In March, GL Capital, Ally Bridge and Giant Star Global proposed to take private Shandong Luoxin Pharmaceutical Group Stock Co. Ltd....

...the remainder. The deal is subject to shareholder approval. Shandong Luoxin Pharmaceutical Group Stock Co. Ltd. (HKSE:8058), Linyi, China Business: Pharmaceuticals Alicia Parker Shandong Luoxin Pharmaceutical Group Stock Co. Ltd....

...investor syndicate including Ally Bridge, GL Instrument Investment and Giant Star Global plans to take Shandong Luoxin Pharmaceutical Group Stock Co. Ltd....
...the WuXi transaction in terms of size and impact (see BioCentury, Aug. 15, 2016) . Becky Simon Shandong Luoxin Pharmaceutical Group Stock Co. Ltd....

...2016 ). Yuhan Corp. (KSE:000100), Seoul, South Korea Shandong Luoxin Pharmaceutical Group Stock Co. Ltd. (HKSE:8058), Linyi, China Business: Cancer Jaime De Leon YH25448 Shandong Luoxin Pharmaceutical Group Stock Co. Ltd. Yuhan...